查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935698

腎臟和膽道支架系統市場按類型、設計、材料、應用和最終用戶分類，全球預測（2026-2032）

Renal & Biliary Stent System Market by Type, Design, Material, Application, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腎臟和膽道支架系統市場價值將達到 45.1 億美元，到 2026 年將成長至 47.3 億美元，到 2032 年將達到 64.8 億美元，複合年成長率為 5.32%。

關鍵市場統計數據
基準年 2025 45.1億美元
預計年份：2026年 47.3億美元
預測年份 2032 64.8億美元
複合年成長率 (%) 5.32%

全面概述腎臟和膽道支架系統，說明臨床作用、技術權衡以及相關人員的決策因素，以期改善病患預後。

腎臟和膽道支架系統領域融合了介入醫學、器材工程和複雜的治療路徑。這些器械對於恢復和維持膽道和泌尿道的通暢性至關重要，其臨床效用範圍涵蓋安寧療護、術後照護和長期疾病管理。過去十年，支架材料、輸送系統和影像引導技術的不斷改進，為臨床醫生提供了更多選擇。然而，諸如生物膜形成、支架移位、組織侵入以及可回收性等持續存在的臨床挑戰，仍然是推動創新發展的關鍵因素。

技術進步、監管演變、供應鏈韌性以及以價值為導向的醫療如何共同重塑支架的研發和臨床應用？

腎臟和膽道支架領域正受到技術、臨床和政策主導因素的共同影響而重塑。材料科學的進步使得支架結構更具適應性和耐用性，而成像和輸送系統的改進則提高了微創手術的精確性和可重複性。因此，臨床醫生有更多機會根據特定的解剖和病理情況選擇合適的器械，這影響著器械的使用壽命和術後管理。與這些技術變革相呼應的是，對以價值為導向的醫療服務和綜合支付模式的重視，正促使醫院和門診中心優先選擇能夠降低再入院率、縮短手術時間和減少併發症發生率的器械。

評估 2025 年美國關稅調整對醫療設備市場的籌資策略、供應商關係和成本控制重點的影響。

美國2025年實施的新關稅為醫療設備製造商和醫療系統的採購和供應鏈規劃增添了新的策略維度。關稅調整影響了進口零件和成品的成本結構，迫使企業重新評估供應商關係、合約條款和庫存政策。為此，製造商正在探索近岸外包、供應商多元化和提高垂直整合程度等措施，以減輕跨境關稅對利潤率的影響。

全面的細分分析能夠深入洞察類型、設計、材質、臨床應用和最終用戶環境如何共同決定設備選擇和創新重點。

細分市場分析揭示了器械特性和臨床應用背景如何共同驅動產品差異化和市場接受度。就類型而言，當需要精確的徑向支撐力和可預測的展開時，球囊擴張型支架往往是首選；而自動擴張型支架則能為迂曲的血管解剖結構和動態管腔提供良好的貼合性和持續的向外支撐力。從類型到設計，覆膜支架和裸支架之間的差異直接影響臨床權衡。覆膜支架可以限制組織侵入並簡化取出過程，但可能增加移位和阻塞的風險。另一方面，裸支架有利於排放透過側支引流，但隨著時間的推移，可能更容易發生組織侵入。

區域差異分析：闡述基礎設施、報銷模式和臨床實務的差異如何導致產品引進和商業化策略的差異。

區域趨勢揭示了美洲、歐洲、中東和非洲以及亞太地區醫療基礎設施、報銷框架和臨床醫生實踐模式差異所導致的不同的技術採納路徑。在美洲，先進的介入治療網路和高手術量促進了創新治療系統和精密設備的快速普及。同時，完善的採購流程促使採購者在選擇產品時優先考慮生命週期成本和療效。另一方面，在歐洲、中東和非洲，報銷模式和法規環境的差異凸顯了該地區的多樣性。在這個複雜的區域內，某些市場強調真實世界安全性數據和長期後續觀察，而其他市場則優先考慮成本控制和集中採購。

策略競爭概覽：產品創新、監管策略和供應鏈選擇決定了市場領導和挑戰者。

腎膽支架領域的企業競爭體現在產品創新、監管應對力與策略聯盟三者之間的平衡。主要企業正致力於漸進式和基礎性創新，以應對移位、阻塞和回收等挑戰，同時最佳化輸送系統以縮短手術時間並提高術者效率。同時，精明的新興參與企業和中型市場參與者則專注於細分市場差異化，例如特殊塗層、塗層化學以及整合藥物釋放型和抗菌功能的組合裝置，以在特定臨床領域獲得市場佔有率。

經營團隊需採取具體策略行動，協調設備研發、臨床證據和供應鏈韌性，以追求永續的商業性優勢。

產業領導者應採取切實可行的措施，平衡臨床價值與商業性可行性。首先，優先投資於能夠顯著減少再次手術需求和降低併發症發生率的功能，以滿足關注總成本和以患者為中心的治療結果的利益相關人員的需求。其次，將上市後監測納入產品生命週期，以產生可靠的真實世界數據，從而支持臨床醫生採納和監管合規。這可以透過註冊合作和數位化追蹤解決方案來實現。第三，透過關鍵零件採購多元化、探索區域製造夥伴關係關係以及實施靈活的庫存策略來增強供應鏈韌性，從而減輕關稅和物流中斷的影響。

採用嚴謹的混合方法研究途徑，結合臨床醫師意見、技術審查、監管分析與檢驗，得出可靠的策略見解。

本分析的研究方法透過對臨床實務趨勢、醫療設備設計原則和商業策略進行質性綜合分析，得出可操作的見解。主要資料來源包括臨床醫生訪談、技術白皮書、監管指導文件和供應鏈評估，旨在闡明器械設計的權衡取捨、重要性以及臨床應用案例。二級資訊來源包括對同行評審的臨床文獻和已發布的監管決策的分析，用於評估安全性、性能預期和證據生成方法。

指導經營團隊決策和策略調整，以實現將臨床需求與商業性和營運重點結合的綜合成果。

本分析整合了影響腎臟和膽道支架市場的臨床、商業性和營運等各個方面，旨在為行業領導者提供一致的決策框架。臨床方面，當務之急顯而易見：器械必須減輕手術負擔、最大限度地減少併發症，並支持以病人為中心的診療路徑。商業性，能夠使器械特性與支付方預期相符，並透過真實世界數據證明其價值的企業將獲得成功。在營運方面，供應鏈的韌性和區域生產考量是決定可靠性和成本穩定性的關鍵因素。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 腎臟和膽道支架系統市場（按類型分類）

  • 球囊擴張型支架
  • 自動擴張型支架

9. 腎臟和膽道支架系統市場（依設計分類）

  • 覆蓋類型
  • 未塗層

10. 腎臟和膽道支架系統市場（依材料分類）

  • 由金屬製成
    • 鎳鈦諾
    • 不銹鋼
  • 由聚合物製成
    • 聚四氟乙烯
    • 矽酮

第11章 按應用分類的腎臟和膽道支架系統市場

  • 良性膽道狹窄
    • 術後狹窄
    • 原發性硬化性膽管炎
  • 惡性膽道阻塞
    • 膽管癌
    • 胰臟癌
  • 輸尿管阻塞
    • 良性
    • 惡性
  • 輸尿管狹窄
    • 良性
    • 惡性

12. 按最終用戶分類的腎臟和膽道支架系統市場

  • 門診手術中心
  • 醫院和診所
    • 綜合醫院
    • 專科診所

13. 各地區腎臟及膽道支架系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

14. 腎臟和膽道支架系統市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國腎臟及膽道支架系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國腎臟及膽道支架系統市場

第17章 中國腎臟與膽道支架系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Endo-Flex GmbH by Medi-Globe
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nanjing Micro-Tech Medical（Group）Co., Ltd.
  • Nipro Corporation
  • Olympus Corporation
  • Sahajanand Medical Technologies Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-9A6A6F2974B9

The Renal & Biliary Stent System Market was valued at USD 4.51 billion in 2025 and is projected to grow to USD 4.73 billion in 2026, with a CAGR of 5.32%, reaching USD 6.48 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.51 billion
Estimated Year [2026] USD 4.73 billion
Forecast Year [2032] USD 6.48 billion
CAGR (%) 5.32%

A comprehensive orientation to renal and biliary stent systems that explains clinical roles, engineering trade-offs, and stakeholder decision drivers for better patient outcomes

The renal and biliary stent system landscape sits at the intersection of interventional medicine, device engineering, and complex care pathways. These devices are integral to restoring and maintaining luminal patency in the biliary and urinary tracts, and their clinical utility spans palliative management, postoperative care, and long-term disease control. Over the past decade, incremental improvements in stent materials, delivery systems, and imaging guidance have coalesced into a more refined set of options for clinicians, yet persistent clinical challenges-such as biofilm formation, migration, tissue ingrowth, and the need for retrievability-continue to shape innovation priorities.

Clinicians, manufacturers, and procurement professionals now evaluate stent choices through a multidimensional lens that includes procedural efficiency, patient-centered outcomes, and total cost of care. As a result, the discussion has shifted from device-centric specifications to broader considerations of clinical pathways and systems-level value. This introduction frames the subsequent analysis by clarifying the clinical imperatives that drive device selection, the engineering trade-offs implicit in design and material choices, and the regulatory and reimbursement realities that influence how these products are brought to market and adopted in practice.

In sum, appreciating both the technical attributes of renal and biliary stents and the contextual demands of care delivery is essential for stakeholders seeking to prioritize development, refine product portfolios, or optimize procurement strategies. This foundation enables a focused exploration of the transformative dynamics, segmentation nuances, regional variations, and competitive behaviors that follow.

How technological advancements, regulatory evolution, supply chain resilience, and value-based care are collectively reshaping stent development and clinical adoption

The landscape for renal and biliary stents is being reshaped by a convergence of technological, clinical, and policy-driven forces. Advancements in materials science have enabled more compliant and durable constructs, while improvements in imaging and delivery systems have made minimally invasive procedures more precise and reproducible. Consequently, clinicians are increasingly able to tailor device choice to specific anatomical and pathological circumstances, which in turn influences device lifecycle and post-procedural management. Alongside these technological shifts, an emphasis on value-based care and bundled payment models has prompted hospitals and ambulatory centers to prioritize devices that reduce readmissions, shorten procedure times, and lower complication rates.

Regulatory pathways are also evolving, with authorities placing greater emphasis on real-world evidence and post-market surveillance. This creates both opportunities and obligations for manufacturers to demonstrate long-term safety and performance beyond traditional bench testing. Concurrently, supply chain resilience and manufacturing agility have become strategic differentiators following recent global disruptions. Organizations that invest in diversified sourcing, robust quality systems, and flexible production processes are better positioned to manage disruptions and meet clinician demand.

Finally, the patient experience is increasingly central to innovation agendas. Initiatives that reduce the need for repeat interventions, improve symptomatic relief, and enable outpatient management are gaining priority. Together, these transformative shifts redefine competitive advantage and suggest that the next wave of differentiation will come from integrated solutions that combine superior device characteristics with services that optimize clinical pathways and patient outcomes.

Assessment of how 2025 tariff adjustments in the United States are influencing procurement strategies, supplier relationships, and cost-management priorities in device markets

The introduction of new tariff measures in the United States during 2025 has added an additional strategic dimension to procurement and supply chain planning for medical device companies and health systems alike. Tariff adjustments have influenced cost structures for imported components and finished devices, prompting organizations to reassess supplier relationships, contract terms, and inventory policies. In response, manufacturers have explored near-shoring, supplier diversification, and increased vertical integration to mitigate the margin impact of cross-border duties.

Procurement functions within hospitals and ambulatory centers have reacted by revisiting total-cost-of-ownership considerations and placing higher emphasis on predictable pricing, lead times, and contractual protections. As a result, negotiation dynamics between suppliers and buyers have shifted toward multi-year agreements with built-in contingencies and collaborative forecasting. This, in turn, has implications for smaller innovators whose supply chains are more exposed to tariff volatility and who may face heightened barriers to entry unless they secure strategic partnerships or localized manufacturing capabilities.

Importantly, the tariff environment has also accelerated conversations around value engineering and cost optimization in device design. Manufacturers are balancing material choices and manufacturing processes to preserve clinical performance while managing landed costs. In summary, the cumulative effect of tariff changes has been to elevate supply chain strategy and procurement sophistication as central elements of commercial planning, influencing how organizations prioritize investments and structure go-to-market approaches.

Comprehensive segmentation insights detailing how type, design, material, clinical application, and end-user settings jointly determine device selection and innovation focus

Segmentation analysis reveals how device characteristics and clinical contexts jointly drive product differentiation and adoption patterns. When types are compared, balloon-expandable stents tend to be selected where precise radial force and predictable deployment are critical, while self-expanding stents offer conformability and continuous outward force suited to tortuous anatomy and dynamic lumens. Moving from type to design, the covered versus uncovered distinction directly affects clinical trade-offs: covered designs reduce tissue ingrowth and can simplify removal but may increase the risk of migration and occlusion, whereas uncovered designs facilitate biliary drainage through side branches but can be prone to ingrowth over time.

Material selection further nuances device performance and manufacturing complexity. Metallic constructs, commonly fabricated from nitinol or stainless steel, provide predictable radial strength and fatigue resistance; nitinol offers superior conformability and shape-memory behavior, while stainless steel can deliver cost advantages and specific mechanical profiles. Polymeric alternatives-including polytetrafluoroethylene and silicone-offer distinct biocompatibility and flexibility characteristics and are frequently used in covered or entirely polymeric designs to mitigate biofilm adherence and facilitate retrievability. These material choices have downstream implications for sterilization, shelf life, and imaging compatibility.

Clinical application is another pivotal lens. Devices intended for benign biliary strictures, which include post-surgical strictures and those arising from primary sclerosing cholangitis, prioritize long-term patency and low complication rates; by contrast, stents used for malignant biliary obstruction-such as those associated with cholangiocarcinoma or pancreatic cancer-often emphasize palliation and durable lumen maintenance in the context of limited life expectancy. Ureteral obstructions and ureteral strictures, whether benign or malignant, require attention to ureteral peristalsis, encrustation tendencies, and the need for exchange or removal. Finally, end-user setting shapes procurement and product design considerations: ambulatory surgical centers tend to prioritize single-use, easy-to-deploy systems that support rapid turnover, whereas hospitals and specialty clinics may favor devices that offer retrievability, advanced imaging compatibility, and supply chain consistency. The interplay of these segmentation dimensions drives targeted product development, regulatory strategy, and commercialization planning.

Regional differentiation analysis explaining how infrastructure, reimbursement models, and clinical practice variations drive divergent adoption and commercialization strategies

Regional dynamics reveal differentiated adoption pathways shaped by healthcare infrastructure, reimbursement frameworks, and clinician practice patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced interventional networks and high procedure volumes support rapid uptake of innovative delivery systems and premium device features, while procurement sophistication leads buyers to weigh life-cycle costs and outcomes when selecting products. By contrast, Europe, the Middle East & Africa exhibit heterogeneity driven by divergent reimbursement models and regulatory environments; certain markets within this combined region place a premium on real-world safety data and long-term surveillance, whereas others emphasize cost containment and centralized purchasing.

Asia-Pacific encompasses a broad spectrum of healthcare maturity, from highly specialized tertiary centers that quickly adopt novel devices to regions where infrastructure constraints favor simpler, cost-effective solutions. Reimbursement policies and public procurement practices in many Asia-Pacific markets influence device standardization and the pace of technology diffusion. Across all regions, common themes emerge: the need for robust clinician training programs, the importance of post-market evidence to support clinical guidelines, and the role of local manufacturing or supply partnerships in ensuring availability. These regional contrasts inform market-entry strategies and indicate that a one-size-fits-all commercialization approach will be less effective than regionally tailored tactics that align with payer expectations, clinical capacity, and logistical realities.

Strategic competitive overview showing how product innovation, regulatory strategy, and supply chain choices are defining market leaders and challengers

Competitive behavior among companies in the renal and biliary stent arena reflects a balance between product innovation, regulatory acumen, and strategic partnerships. Leading firms are investing in incremental and platform innovations that address migration, occlusion, and retrievability while simultaneously optimizing delivery systems to reduce procedure time and improve operator ergonomics. At the same time, savvy entrants and mid-tier players are focusing on niche differentiation-such as specialized coverings, coating chemistries, or combination devices that integrate drug elution or antibacterial features-to carve share in defined clinical segments.

Regulatory strategy has become a significant determinant of market positioning; companies that demonstrate robust post-market surveillance and generate real-world evidence are better able to navigate approvals and secure clinician trust. Collaboration with clinical investigators and health systems is also a feature of successful commercial models, enabling iterative design improvements and early adoption within centers of excellence. Moreover, supply chain strategy, including manufacturing footprint and supplier diversity, is increasingly visible in competitive comparisons. Firms that align their commercial narratives with demonstrable outcomes, procurement value, and clinician satisfaction tend to sustain longer-term relationships with high-volume users and payers. Thus, competitive advantage is being defined not solely by device specs but by an integrated approach that couples engineering excellence with regulatory, clinical, and operational capabilities.

Concrete strategic actions for executives to align device development, clinical evidence, and supply chain resilience in pursuit of sustainable commercial advantage

Industry leaders should pursue a set of pragmatic actions that align clinical value with commercial viability. First, prioritize investments in features that demonstrably reduce the need for repeat procedures and lower complication rates, thereby resonating with stakeholders focused on total cost and patient-centered outcomes. Second, integrate post-market surveillance into product lifecycles to generate robust real-world evidence that supports clinician adoption and regulatory compliance; this can be achieved through registry partnerships and digital follow-up solutions. Third, strengthen supply chain resilience by diversifying critical component sourcing, exploring regional manufacturing partnerships, and implementing flexible inventory strategies to mitigate tariff and logistics disruptions.

In parallel, commercial teams should tailor market-entry strategies to regional payer and procurement dynamics, ensuring that pricing and value propositions reflect local expectations. Collaborations with clinical champions and early adopter sites remain essential for generating clinical momentum; therefore, investing in training, proctoring, and peer-to-peer education will accelerate uptake. Finally, consider service-based offerings and bundled solutions that combine devices with procedural support, data analytics, or warranty arrangements to create differentiated value propositions. Collectively, these actions will help companies reduce adoption friction, improve patient outcomes, and sustain commercially viable portfolios in a complex and evolving environment.

Rigorous mixed-methods research approach combining clinician input, technical review, regulatory analysis, and validation to produce defensible strategic insights

The research approach underpinning this analysis combined qualitative synthesis of clinical practice trends, device engineering principles, and commercial strategy to produce actionable insights. Primary inputs included clinician interviews, technical white papers, regulatory guidance documents, and supply chain assessments, all of which were synthesized to characterize device design trade-offs, material implications, and clinical use cases. Secondary sources comprised peer-reviewed clinical literature and publicly available regulatory decisions that informed assessments of safety, performance expectations, and evidence-generation practices.

To ensure analytical rigor, findings were triangulated across multiple data streams and validated through expert consultations with interventional specialists, procurement leaders, and regulatory affairs professionals. Where appropriate, sensitivity checks and scenario-based reasoning were employed to evaluate the robustness of strategic implications against variations in reimbursement policy and supply chain disruption. Limitations of the methodology include the variability of reporting across regions and the evolving nature of real-world evidence; therefore, conclusions emphasize durable strategic principles rather than time-bound quantitative estimates. Overall, the methodology is designed to provide a defensible basis for decision-making while acknowledging areas where additional primary data collection could further refine tactical choices.

Integrated conclusion that ties clinical imperatives to commercial and operational priorities to guide executive decision-making and strategic alignment

This analysis synthesizes the clinical, commercial, and operational dimensions that shape the renal and biliary stent environment to provide leaders with a cohesive decision framework. Clinically, the imperative is clear: devices must reduce procedural burden, minimize complications, and support patient-centered care pathways. Commercially, success will accrue to organizations that align device features with payer expectations and that substantiate value through real-world evidence. Operationally, supply chain resilience and regional manufacturing considerations have become key determinants of reliability and cost stability.

Taken together, these perspectives indicate that competitive advantage will increasingly rest on integrated solutions that combine superior device attributes with evidence generation, clinician enablement, and robust procurement support. Strategic priorities should therefore emphasize cross-functional alignment across R&D, clinical affairs, and commercial teams to ensure that product roadmaps respond to both procedural realities and systemic incentives. In closing, stakeholders who adopt a holistic approach-balancing technical innovation with evidence, operational robustness, and regional market intelligence-will be best positioned to deliver sustained clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Renal & Biliary Stent System Market, by Type

  • 8.1. Balloon-Expandable Stent
  • 8.2. Self-Expanding Stent

9. Renal & Biliary Stent System Market, by Design

  • 9.1. Covered
  • 9.2. Uncovered

10. Renal & Biliary Stent System Market, by Material

  • 10.1. Metallic
    • 10.1.1. Nitinol
    • 10.1.2. Stainless Steel
  • 10.2. Polymeric
    • 10.2.1. Polytetrafluoroethylene
    • 10.2.2. Silicone

11. Renal & Biliary Stent System Market, by Application

  • 11.1. Benign Biliary Stricture
    • 11.1.1. Post Surgical Stricture
    • 11.1.2. Primary Sclerosing Cholangitis
  • 11.2. Malignant Biliary Obstruction
    • 11.2.1. Cholangiocarcinoma
    • 11.2.2. Pancreatic Cancer
  • 11.3. Ureteral Obstruction
    • 11.3.1. Benign
    • 11.3.2. Malignant
  • 11.4. Ureteral Stricture
    • 11.4.1. Benign
    • 11.4.2. Malignant

12. Renal & Biliary Stent System Market, by End Users

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals & Clinics
    • 12.2.1. General Hospitals
    • 12.2.2. Specialty Clinics

13. Renal & Biliary Stent System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Renal & Biliary Stent System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Renal & Biliary Stent System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Renal & Biliary Stent System Market

17. China Renal & Biliary Stent System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. B. Braun Melsungen AG
  • 18.7. Becton Dickinson and Company
  • 18.8. Boston Scientific Corporation
  • 18.9. Cook Medical LLC
  • 18.10. Endo-Flex GmbH by Medi-Globe
  • 18.11. Johnson & Johnson Services, Inc.
  • 18.12. Medtronic plc
  • 18.13. Merit Medical Systems, Inc.
  • 18.14. Nanjing Micro-Tech Medical (Group) Co., Ltd.
  • 18.15. Nipro Corporation
  • 18.16. Olympus Corporation
  • 18.17. Sahajanand Medical Technologies Limited
  • 18.18. Teleflex Incorporated
  • 18.19. Terumo Corporation
  • 18.20. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SELF-EXPANDING STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SELF-EXPANDING STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SELF-EXPANDING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POST SURGICAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POST SURGICAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POST SURGICAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PRIMARY SCLEROSING CHOLANGITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PRIMARY SCLEROSING CHOLANGITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PRIMARY SCLEROSING CHOLANGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 214. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 215. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 216. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 217. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 220. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 222. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 253. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 254. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 255. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 256. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 259. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 260. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 262. G7 RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 266. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 267. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 268. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 269. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 272. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 273. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 274. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 275. NATO RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY METALLIC, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY POLYMERIC, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN BILIARY STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT BILIARY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY URETERAL STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA RENAL & BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)